HIMS Rating

HIMS Intrinsic Value

Key Highlights:
As of Mar 03, 2025 HIMS Relative Value is $23.2, which is overvalued by 43.1%, compared to current share price of $40.7.
As of Mar 03, 2025 HIMS DCF Value is N/A, which is undervalued by N/A, compared to current share price of $40.7.
Methodology
Price per share, $
Current share price
40.7
DCF value
not available

HIMS Share Price History

1W (20.7%)
1M 4.5%
6M 180.6%
YTD 322.0%
1Y 176.7%
3Y 731.9%
5Y 305.3%
10Y 315.1%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!

HIMS Stock Metrics

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$9,261.6M
$1,476.5M
Shares Outstanding
228M
Employees
N/A
Valuation (LTM)
143.5x
46.7x
73.5x
19.4x
(0.1x)
Return on Capital
27.5%
19.2%
55.5%
25.0%
(12.2%)
1,926.0%
1,926.0%
Earnings
May 05, 2025
MISS by (16.9%)
MISS by 0.0%
7 Beat & 3 Miss

HIMS Stock Financials

HIMS Income Statement Metrics

Annual
Quarterly
LTM

Revenue

$872.0M +65.5% YoY

Operating Income

($29.5M) -57.1% YoY

Net Income

($23.5M) -64.1% YoY

HIMS Cash Flow Statement Metrics

Annual
Quarterly
LTM

Capital Expenditure (CAPEX)

($26.5M) +265.6% YoY

Free Cash Flow (FCF)

$47.0M N/A YoY

HIMS Income Statement Overview

Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$872.0M 65.5% YoY
$714.9M 74.9% YoY
82.0% margin
Cost of revenue
$157.1M 32.9% YoY
Operating expenses
$744.4M 55.9% YoY
Net income
$23.5M (64.1%) YoY
(2.7%) margin
Other: $20.1M
R&D
$48.2M 65.0% YoY
5.5% of revenue
SG&A
$692.7M 86.8% YoY
79.4% of revenue

HIMS Balance Sheet Overview

Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$441.2M
Current assets ($265.1M, 60.1% of total)
$221.0M (50.1%)
$5,705.0K (1.3%)
Other current assets
$38.4M (8.7%)
Non-current assets ($176.1M, 39.9% of total)
$18.6M (4.2%)
Other non-current assets
$111.8M (25.3%)
Financial position
($209.8M)
$221.0M$11.2M
Cash & Short-term Investments
Total Debt

HIMS Stock Ratios

HIMS Earnings Surprises

Crunching data... Almost there!

HIMS Dividends

HIMS Dividend Yield

Crunching data... Almost there!

HIMS Dividend Per Share

Competing with HIMS

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Quality rating
Intrinsic value
1Y Return
Revenue
Free Cash Flow
Revenue growth
FCF margin
Gross margin
ROIC
Total Debt to Equity
$9,261.6M
7.3
$22.2
45.4% overvalued
176.7%
$1,476.5M
$198.3M
69.3%
13.4%
76.6%
55.5%
2.4%
$411.8B
7.1
$135.9
22.6% overvalued
12.1%
$84.3B
$16.7B
0.5%
19.8%
51.3%
19.2%
67.4%
$143.6B
7.0
$90.7
57.2% undervalued
20.3%
€120.4B
€15.8B
7.0%
13.1%
71.4%
31.3%
142.1%
$75.3B
7.0
$83.3
10.2% overvalued
8.6%
$20.1B
$3,546.0M
3.3%
17.6%
60.5%
30.9%
1,564.7%
$47.9B
6.4
$160.0
11.6% undervalued
20.3%
$20.1B
$2,513.0M
(1.8%)
12.5%
35.8%
28.9%
705.1%
$45.5B
5.8
$21.1
11.3% overvalued
29.2%
$15.5B
$1,335.0M
0.1%
8.6%
57.9%
10.1%
90.2%
$27.1B
6.3
$79.8
28.8% overvalued
11.9%
$6,107.1M
$976.4M
4.1%
16.0%
45.2%
8.9%
41.1%
$25.7B
5.0
$93.6
33.4% undervalued
(51.7%)
$15.2B
$1,145.0M
0.1%
7.6%
73.1%
0.2%
225.1%
$19.3B
6.6
$117.2
24.8% overvalued
5.0%
$7,165.0M
$695.0M
(2.0%)
9.7%
44.5%
38.2%
2,555.4%
$4,901.6M
5.1
$15.4
182.3% undervalued
(56.1%)
$6,090.4M
$293.5M
1.3%
4.8%
64.6%
7.0%
7.8%
$3,814.9M
6.1
$64.1
0.4% undervalued
(69.5%)
$1,302.0M
$24.6M
46.3%
1.9%
71.1%
15.2%
39.4%

FAQ

What is Hims & Hers Health, Inc. (HIMS) stock rating?

As of today, Hims & Hers Health, Inc. has a stock rating of 7 (out of 10), which is considered Great.

is Hims & Hers Health, Inc. (HIMS) a good stock to buy?

As of today, Hims & Hers Health, Inc. has a Great stock rating, which is 45.4% overvalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 0.5%.